The bankrupt genetic testing company 23andme is selling all its users' genetic data to biotech drug developer Regeneron Pharmaceuticals as part of the latter’s acquisition of (most of) the company.

Time to delete your data if you’re not comfortable with this. Otherwise, it sounds like they intend to keep running 23andme roughly as is, for now.